We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
A new world is possible. Let's not go back to what wasn't working anyway.
Add this topic to your myFT Digest for news straight to your inbox
UK pharma group to commercialise 26 drug targets using technology proven with Covid-19 vaccines
Agency decision to restrict third jabs to vulnerable Americans deals blow to Biden’s strategy
Joe Biden urges other wealthy countries to follow suit in a bid to boost access around the world
Lawyers warn of risk contravening anti-discrimination rules
Asian Development Bank says economic recovery in some countries is being held back by Covid outbreaks
President resisted at first but was convinced reopening border would help US jab campaign
Treating the growing numbers of unvaccinated patients is fuelling compassion fatigue and resentment
Companies say data provide ‘strong foundation’ to seek authorisation to vaccinate 5-11 age group
About-turn over imports of jabs helps new hardline administration battle the pandemic
Holdouts among hospital and care home staff face suspension but government says mandatory vaccination has worked
Advisory committee endorses third dose only for elderly and at-risk groups in blow to Biden
Chief of Serum Institute criticises ‘unethical’ behaviour of wealthy nations pursuing Covid booster jabs
The UK government’s confused handling of the situation has only fuelled distrust
Analysts predict revenues from Covid-19 jabs will fall precipitously by 2024
Not every unvaccinated person believes Covid-19 jabs are a genocidal conspiracy
Requirement would be strictest measure in Europe so far to curtail movement based on vaccination status
Data come as US regulator weighs approval for booster shot to bolster immunity
Several pharma groups are hoping the Covid vaccine race will turn out to be a marathon, not a sprint
International Edition
